Cutler Group LP Enanta Pharmaceuticals Inc Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 06, 2020	SELL	$57.95 - $66.61 $57,950 - $66,610	-1,000 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$60.08 - $88.17 $120,160 - $176,340	-2,000 Reduced 66.67%	1,000 $1,000
Q3 2018 Nov 07, 2018	BUY	$85.46 - $126.37 $205,103 - $303,288	2,400 Added 400.0%	3,000 $2,000
Q2 2018 Aug 10, 2018	SELL	$81.85 - $120.51 $49,110 - $72,306	-600 Reduced 50.0%	600 $18,000
Q1 2018 May 11, 2018	BUY	$57.91 - $92.15 $69,492 - $110,580	1,200 New	1,200 $3,000
Q4 2017 Jan 17, 2018	SELL	$45.65 - $59.37 $13,695 - $17,811	-300 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$37.91 - $46.8 $11,372 - $14,040	300	300 $3,000

107

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $102M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.